Francesca L. Beaudoin MD, MS, PhD is a board-certified practicing emergency physician and clinical epidemiologist with expertise in opioid use disorders and adverse post-traumatic health outcomes, particularly pain and substance use. She is Principal Investigator of multiple federal and private grant awards including "Implementing Statewide Emergency Department Care Pathways for Addiction Recovery after Opioid Overdose (R01CE003149)" and a large clinical trial of "ED-based behavioral interventions following opioid overdose: The impact of peer navigation on treatment engagement, relapse, and recovery" (Arnold Ventures Foundation). 

Dr. Beaudoin has written and implemented practice management policies for health care systems on pain management and opioid prescribing, and has served as a member of the Food and Drug Administration Anesthetic and Analgesic Drug Products Advisory Committee.  She has partnered with small businesses to innovate new approaches to solving key public health problems such as the opioid epidemic and was the PI of a NIH STTR award to help develop and evaluate a mobile peer recovery support application.  She collaborates with state stakeholders such as the Rhode Island Department of Health and the Governor’s Task Force on Opioid Overdoses and is a Senior Medical Advisor to the Institute for Clinical and Economic Review (ICER).  

Dr. Marshall is founding director of the People, Place & Health Collective (PPHC) at Brown University. He received a Ph.D. in epidemiology from the School of Population and Public Health at the University of British Columbia. During doctoral training, he worked at the British Columbia Centre for Excellence in HIV/AIDS. In 2011, Marshall completed postdoctoral training at the Columbia University Mailman School of Public Health.

Broadly, Dr. Marshall's work focuses on substance use epidemiology, harm reduction research, and the social, environmental, and structural determinants of health of drug-using populations. He also examines the causes and consequences of drug and alcohol use, including overdose, HIV/AIDS, and hepatitis C virus infection. He is an expert in structural determinants of health; agent-based modeling; evaluation of harm reduction programs; and psychiatric and substance use epidemiology.

Chanelle Howe, Ph.D., is interested in methods, infectious diseases, and health disparities. Howe's methodologically focused research interests include improving understanding of potential sources of bias as well as better characterizing, adapting, and illustrating the use of advanced quantitative methods to promote accurate inference. Substantively, she is interested in using state-of-the-art approaches to identify the best targets for effective interventions to improve HIV-related population health and to reduce persistent health disparities.

Shilo McBurney is an Assistant Professor in the Department of Epidemiology and the concentration lead for Epidemiology students in the Master of Public Health Program. Her research focuses on public health surveillance and interventions, infectious and vaccine-preventable diseases, and data validation. She is passionate about fostering scientific literacy and critical-thinking and is interested in developing best practices for communicating complex scientific concepts to stakeholder communities to drive public health and policy change.

Shilo received her MSc in Epidemiology and Community Health from Dalhousie University in 2016. In 2022, she completed her PhD in Epidemiology at the University of Toronto with a Collaborative Specialization in Public Health Policy. Her PhD dissertation on evaluating pertussis detection in health administrative and surveillance data was funded by a CIHR Doctoral Research Award. Before and after her PhD, Shilo practiced public health directly under the Provincial Cancer Surveillance Epidemiologist in Prince Edward Island with a focus on screening program evaluation.